AU2002221643A1 - Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same - Google Patents

Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same

Info

Publication number
AU2002221643A1
AU2002221643A1 AU2002221643A AU2164302A AU2002221643A1 AU 2002221643 A1 AU2002221643 A1 AU 2002221643A1 AU 2002221643 A AU2002221643 A AU 2002221643A AU 2164302 A AU2164302 A AU 2164302A AU 2002221643 A1 AU2002221643 A1 AU 2002221643A1
Authority
AU
Australia
Prior art keywords
lipooligosaccharide
mimotope
same
vaccines containing
neisseria meningitides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221643A
Other languages
English (en)
Inventor
Xavier Thomas De Bolle
Jean-Jacques Letesson
Yves Lobet
Pascal Yvon Mertens
Jan Poolman
Pierre Voet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2002221643A1 publication Critical patent/AU2002221643A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002221643A 2000-10-03 2001-10-03 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same Abandoned AU2002221643A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0024200.8 2000-10-03
GBGB0024200.8A GB0024200D0 (en) 2000-10-03 2000-10-03 Component vaccine
PCT/EP2001/011409 WO2002028888A2 (fr) 2000-10-03 2001-10-03 Compose pour vaccin

Publications (1)

Publication Number Publication Date
AU2002221643A1 true AU2002221643A1 (en) 2002-04-15

Family

ID=9900594

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221643A Abandoned AU2002221643A1 (en) 2000-10-03 2001-10-03 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same

Country Status (7)

Country Link
US (1) US20040047880A1 (fr)
EP (1) EP1417221A2 (fr)
JP (1) JP2004526418A (fr)
AU (1) AU2002221643A1 (fr)
CA (1) CA2424543A1 (fr)
GB (1) GB0024200D0 (fr)
WO (1) WO2002028888A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
US6936261B2 (en) 2000-07-27 2005-08-30 Children's Hospital & Research Center At Oakland Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
WO2004065409A2 (fr) * 2003-01-22 2004-08-05 Government Of The United States Of America As Represented By The Secretary, Department Of Health Andhuman Services Mimotopes de peptides de lipooligosaccharides provenant d'haemophilus influenzae non typables, utilises comme vaccins
CA2550927A1 (fr) 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. Bacterie gram-negative comportant un niveau de lps reduit dans la membrane externe et utilisation de celle-ci pour traiter une infection bacterienne gram-negative
DE602005027830D1 (de) * 2004-04-05 2011-06-16 Univ Bordeaux 2 Peptide und peptidmimetika die an cd23 binden
US9034345B2 (en) 2005-01-27 2015-05-19 Children's Hospital & Research Center Oakland GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
WO2007060769A1 (fr) * 2005-11-24 2007-05-31 Peptide Door Co., Ltd. Liant de lipopolysaccharide ou de lipide a, et nouveau peptide
AR058736A1 (es) * 2005-12-29 2008-02-20 Ct Ingenieria Genetica Biotech Peptidos mimeticos de carbohidratos y su empleo en formulaciones farmaceuticas
AR059851A1 (es) * 2006-03-16 2008-04-30 Genentech Inc Anticuerpos de la egfl7 y metodos de uso
JP5275982B2 (ja) * 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
WO2008124719A1 (fr) 2007-04-09 2008-10-16 Pricelock, Inc. Système et procédé de prime d'assurance pour protection des prix
US7945501B2 (en) 2007-04-09 2011-05-17 Pricelock, Inc. System and method for constraining depletion amount in a defined time frame
US20080261098A1 (en) * 2007-04-20 2008-10-23 General Electric Company Proton-conducting membranes for electrochemical devices, and related articles and processes
US7741576B2 (en) * 2007-05-11 2010-06-22 General Electric Company Apparatus and method for hybrid machining a workpiece
US7976694B2 (en) * 2007-07-17 2011-07-12 General Electric Company Apparatus and method for hybrid machining a contoured, thin-walled workpiece
GB0718966D0 (en) * 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
US8160952B1 (en) 2008-02-12 2012-04-17 Pricelock, Inc. Method and system for providing price protection related to the purchase of a commodity
RU2477145C2 (ru) * 2008-05-30 2013-03-10 ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
AU2009268937A1 (en) * 2008-06-16 2010-01-14 Aj Park Compositions for inducing immune responses specific to Globo H and SSEA3 and uses thereof in cancer treatment
BRPI1007706A2 (pt) 2009-05-08 2019-04-02 Genentech, Inc. anticorpo anti-egfl7, anticorpo biespecífico, ácido nucléico, vetor, célula hospedeira, composição, método para produzir um anticorpo anti-egfl7, método de redução ou inibição da angiogênese em um indivíduo, método de acentuação da eficácia de um agente antiangiogênese em um indivíduo e método de redução ou inibição da perfusão e permeabilidade de um tumor em um indivíduo
WO2018013907A1 (fr) * 2016-07-15 2018-01-18 Board Of Regents, The University Of Texas System Peptides pénétrant dans le mucus et dosage de criblage
BR112020017715A2 (pt) * 2018-03-16 2020-12-29 Zoetis Services Llc Vacinas de peptídeo contra interleucina-31
WO2023119337A1 (fr) * 2021-12-24 2023-06-29 Sentcell Ltd Inhibiteurs de complexes sestrine-mapk

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
US5597725A (en) * 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
IT1270939B (it) * 1993-05-11 1997-05-26 Angeletti P Ist Richerche Bio Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
JP4150082B2 (ja) * 1996-08-27 2008-09-17 カイロン コーポレイション 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
US6951924B2 (en) * 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
CA2305690A1 (fr) * 1997-10-09 1999-04-22 Human Genome Sciences, Inc. 53 proteines secretees humaines
US20030017497A1 (en) * 1998-02-04 2003-01-23 Thomas Kieber-Emmons Peptide mimotopes of carbohydrate antigens
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
DE69939527D1 (de) * 1998-03-13 2008-10-23 Burnham Inst Zielsuchende verbindungen für verschiedene organe und gewebe
US6174687B1 (en) * 1999-02-26 2001-01-16 The Burnham Institute Methods of identifying lung homing molecules using membrane dipeptidase
WO2000020434A1 (fr) * 1998-10-02 2000-04-13 The Board Of Trustees Of The Leland Stanford Junior University Proteine-1 d'asymetrie analogue a la cadherine, et ses procedes d'utilisation
GB9823835D0 (en) * 1998-10-30 1998-12-23 Univ London Component for vaccine
US20030103992A1 (en) * 1999-10-21 2003-06-05 Arbor Vita Corporation Clasp membrane proteins
PT2281843T (pt) * 2000-06-16 2017-01-02 Human Genome Sciences Inc Anticorpos que se ligam imunoespecificamente a blys
DE60139690D1 (de) * 2000-07-03 2009-10-08 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
AU2002252638A1 (en) * 2001-04-17 2002-10-28 Children's Hospital Oakland Research Institute Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
DE60232071D1 (de) * 2001-06-11 2009-06-04 Applied Nanosystems Bv Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
WO2003015714A2 (fr) * 2001-08-21 2003-02-27 Myriad Genetics, Inc Compositions et methodes therapeutiques pour infections virales

Also Published As

Publication number Publication date
WO2002028888A2 (fr) 2002-04-11
US20040047880A1 (en) 2004-03-11
GB0024200D0 (en) 2000-11-15
CA2424543A1 (fr) 2002-04-11
EP1417221A2 (fr) 2004-05-12
JP2004526418A (ja) 2004-09-02
WO2002028888A3 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2002221643A1 (en) Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2001261470A1 (en) Online presentation system for home pictures and structures
EP1291377B8 (fr) Compose de silicone et preparation cosmetique
GB0103822D0 (en) Products with ETPA-based icons such as candles and room fresheners
AU2001291702A1 (en) People counter
AU2002352903A1 (en) Mesoporous materials and methods
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL152315A0 (en) Soluble ctla4 mutant molecules and pharmaceutical compositions containing the same
AU2001294093A1 (en) Techniques for hiding network element names and addresses
EP1421384A4 (fr) Hprp4 en tant que modificateurs de la voie de passage p53 leurs et methodes d'utilisation
AU2002215014A1 (en) Method and device for the preparation of fuels
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
AU2002250500A1 (en) Decorative container and lid
AU2002337916A1 (en) Modifier of the p53 pathway and methods of use
AU6752101A (en) Accessing services and products via the internet
AU2001235834A1 (en) Closure device for the diffusion of aroma
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001266845A1 (en) Modulation of immune response and methods based thereon
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2000245998A1 (en) Beauty pillow
AU2031301A (en) Shoes capable of being used in the room and outside the room
AU2001277201A1 (en) Angled plane support mechanisms and visual piece support extensions